
Minimum Investment
About Company
Company Name: Biopol Chemicals Limited
Industry / Sector: Specialty Chemicals (Silicones, Emulsifiers, Biochemicals & Polyelectrolytes)
Founded Year: 2023
Promoters: Mr. Santanu Sarkar, Mr. Vedant Sarkar
Incorporated in April 2023, Biopol Chemicals Limited manufactures and distributes 66 specialty chemicals (40 silicone-based, 5 emulsifier-based, 15 biochemicals, 6 polyelectrolytes) for textiles, home care, agriculture, and industrial applications. It operates on a B2B model with installed capacity of 18.25 lakh litres p.a. across units in West Bengal (manufacturing, corporate office, warehouse) and Gujarat (registered office). It has export operations to Bangladesh and 24 employees as on Dec 31, 2025.
IPO Basic Details
| Company Name | Biopol Chemicals Limited |
| IPO Type | SME IPO |
| Price Band | ₹102 – ₹108 |
| Lot Size | 1200 |
| Total Issue Size | ₹31.26 Cr (28,94,400 shares) |
IPO Strengths & Risks
Strengths
- Strong order book
- Dedicated manufacturing unit with quality certifications
- Strategic presence in Gujarat & West Bengal
- Experienced promoters & management
- Export to Bangladesh
Risks
- Raw material price volatility
- Competition in specialty chemicals
- Dependence on textiles/agriculture sectors
- Moderate debt levels
- Expansion execution risk (new land)
IPO Important Dates
| IPO Open Date | 06 Feb 2026 |
| IPO Close Date | 10 Feb 2026 |
| Basis of Allotment | 11 Feb 2026 |
| Refund Initiation | 12 Feb 2026 |
| Demat Credit Date | 12 Feb 2026 |
| Listing Date | 13 Feb 2026 |
| Anchor Investor Date | - |
| UPI Mandate Deadline | 10 Feb 2026 |
IPO Objectives
- Capital expenditure for machinery and equipment – -
- Funding working capital requirements – -
- Debt repayment – -
- General corporate purposes – ₹4.04 Cr
Investor Reservation
| QIB Quota | 23.71% (6,86,400 shares) |
| Retail Quota | 33.25% (9,62,400 shares) |
| HNI Quota | 37.81% (10,94,400 shares; bNII 25.21%, sNII 12.60%) |
| Employee Quota | - |
| Shareholder Quota | - |
| Anchor Investor Allocation | - |
Market Lot Details
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 lots | 2400 | ₹2,59,200 |
| Retail Maximum | 2 lots | 2400 | ₹2,59,200 |
| S-HNI Minimum | 3 lots | 3600 | ₹3,88,800 |
| S-HNI Maximum | - | - | - |
| B-HNI Minimum | 8 lots | 9600 | ₹10,36,800 |
Key Performance Indicators (KPI)
| ROE | 36.32% (Dec 2025) / 38.10% (FY25) |
| ROCE | 26.32% (Dec 2025) / 30.57% (FY25) |
| RoNW | 30.74% (Dec 2025) / 32.00% (FY25) |
| PAT Margin | 12.29% (Dec 2025) / 8.84% (FY25) |
| EBITDA Margin | 18.41% (Dec 2025) / 13.30% (FY25) |
| EPS | ₹5.47 (pre) / ₹7.41 (post) |
| NAV per share | N/A |
| Debt to Equity | 0.76 (Dec 2025) / 0.57 (FY25) |
| P/E Ratio | 19.73x (pre) / 14.58x (post) |
| Industry P/E | 20–40x (specialty chemicals) |
Company Financial Data
| Period | Assets | Total Income | PAT | EBITDA | Net Worth | Borrowings |
|---|---|---|---|---|---|---|
| 31 Mar 2024 | ₹17.56 Cr | ₹17.43 Cr | ₹2.96 Cr | ₹4.43 Cr | ₹9.20 Cr | ₹3.58 Cr |
| 31 Mar 2025 | ₹31.48 Cr | ₹49.15 Cr | ₹4.33 Cr | ₹6.53 Cr | ₹13.53 Cr | ₹7.69 Cr |
| 31 Dec 2025 | ₹48.88 Cr | ₹48.97 Cr | ₹6.00 Cr | ₹8.99 Cr | ₹19.54 Cr | ₹14.92 Cr |
Grey Market Premium
| GMP Price | ₹0 – ₹4 (~0–3.7%) |
| Kostak Rate | N/A |
| Subject to Sauda | N/A |
| Last Updated | Feb 2026 |
| Estimated Listing Price | ₹111 (+2.78–3% premium); current ~₹97.25 (as of Mar 18, 2026) |
IPO Subscription Data
| Total Subscription | 22.33x |
| QIB (Ex Anchor) | 21.05x |
| HNI Subscription | 24.49x |
| Retail Subscription | 20.80x |
| Anchor | - |
IPO Intermediaries
Registrar: Bigshare Services Pvt. Ltd.
Registrar Website: https://ipo.bigshareonline.com
IPO Lead Manager(s)
Company Information
Address: D-211, 2nd Floor, Block-D, Sumel Business Park-6, Near Dudheshwar Circle, Dudheshwar, Tavdipura, Ahmedabad, Gujarat 380004
Website: https://biopolchemicals.com/
Email: investors@biopolchemicals.com
Phone: +91-9147076778
IPO Documents
Explore More Investment Opportunities
Discover IPOs, unlisted shares, and broker comparison tools curated for smart investors.